Status:
COMPLETED
Palonosetron Versus Ramosetron for the Prevention of Postoperative Nausea and Vomiting
Lead Sponsor:
Incheon St.Mary's Hospital
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
Ramosetron and palonosetron are more recently developed 5-hydroxytryptamine type 3 receptor antagonists and this randomized double blind study was designed to compare efficacy of ramosetron and palono...
Eligibility Criteria
Inclusion
- ASA Physical Status 1 or 2
- Elective gynaecological laparoscopic surgery of ≥ 1h duration
Exclusion
- Anti-emetics, steroids, or psychoactive medications within 24 h of study initiation
- Vomiting or retching in the 24 h preceding surgery
- Cancer chemotherapy within 4 weeks or emetogenic radiotherapy within 8 weeks before study entry
- Ongoing vomiting from gastrointestinal disease
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01476280
Start Date
May 1 2011
End Date
August 1 2011
Last Update
November 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Incheon St. Mary's hospital
Incheon, South Korea, 403-720